# Mårten Segelmark

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/marten-segelmark/

## Facts

| Field | Value |
| --- | --- |
| Citations | 17,151 |
| Field | Vasculitis and related conditions |
| h-index | 60 |
| i10-index | 162 |
| Last Known Institution | Lund University |
| OpenAlex ID | https://openalex.org/A5028156038 |
| ORCID iD | 0000-0002-1221-0772 |
| Works | 340 |

## Researcher papers

Showing 12 of 16.

- [Rituximab versus Cyclophosphamide in ANCA-Associated Renal Vasculitis](https://scholariq.org/papers/rituximab-versus-cyclophosphamide-in-anca-associated-renal-vasculitis/)
- [Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies](https://scholariq.org/papers/development-and-validation-of-a-consensus-methodology-for-the-classification-of/)
- [EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis](https://scholariq.org/papers/eular-era-edta-recommendations-for-the-management-of-anca-associated-vasculitis/)
- [Genetically Distinct Subsets within ANCA-Associated Vasculitis](https://scholariq.org/papers/genetically-distinct-subsets-within-anca-associated-vasculitis/)
- [EULAR recommendations for the management of ANCA-associated vasculitis: 2022 update](https://scholariq.org/papers/eular-recommendations-for-the-management-of-anca-associated-vasculitis-2022/)
- [Randomized Trial of C5a Receptor Inhibitor Avacopan in ANCA-Associated Vasculitis](https://scholariq.org/papers/randomized-trial-of-c5a-receptor-inhibitor-avacopan-in-anca-associated/)
- [Serum potassium and adverse outcomes across the range of kidney function: a CKD Prognosis Consortium meta-analysis](https://scholariq.org/papers/serum-potassium-and-adverse-outcomes-across-the-range-of-kidney-function-a-ckd/)
- [Change in albuminuria and subsequent risk of end-stage kidney disease: an individual participant-level consortium meta-analysis of observational studies](https://scholariq.org/papers/change-in-albuminuria-and-subsequent-risk-of-end-stage-kidney-disease-an/)
- [Incidence and survival rates in Wegener's granulomatosis, microscopic polyangiitis, Churg-Strauss syndrome and polyarteritis nodosa](https://scholariq.org/papers/incidence-and-survival-rates-in-wegener-s-granulomatosis-microscopic/)
- [Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis: 2-year results of a randomised trial](https://scholariq.org/papers/rituximab-versus-cyclophosphamide-in-anca-associated-renal-vasculitis-2-year/)
- [CKD Progression and Mortality Among Men and Women: A Nationwide Study in Sweden](https://scholariq.org/papers/ckd-progression-and-mortality-among-men-and-women-a-nationwide-study-in-sweden/)
- [Measures of chronic kidney disease and risk of incident peripheral artery disease: a collaborative meta-analysis of individual participant data](https://scholariq.org/papers/measures-of-chronic-kidney-disease-and-risk-of-incident-peripheral-artery/)

## Researcher topics

- [Vasculitis and related conditions](https://scholariq.org/topics/vasculitis-and-related-conditions/)
- [Renal Diseases and Glomerulopathies](https://scholariq.org/topics/renal-diseases-and-glomerulopathies/)
- [Otitis Media and Relapsing Polychondritis](https://scholariq.org/topics/otitis-media-and-relapsing-polychondritis/)
- [Systemic Sclerosis and Related Diseases](https://scholariq.org/topics/systemic-sclerosis-and-related-diseases/)
- [Coagulation, Bradykinin, Polyphosphates, and Angioedema](https://scholariq.org/topics/coagulation-bradykinin-polyphosphates-and-angioedema/)

## Researcher university

- [Lund University](https://scholariq.org/institutions/lund-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.